Published in Adv Surg on January 01, 2010
Minimally invasive and robotic Ivor Lewis esophagectomy. J Thorac Dis (2014) 1.11
OrVil™-assisted anastomosis in laparoscopic upper gastrointestinal surgery: friend of the laparoscopic surgeon. Surg Endosc (2011) 1.03
Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos). Surg Endosc (2014) 0.97
Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medicine (Baltimore) (2014) 0.89
Modified McKeown minimally invasive esophagectomy for esophageal cancer: a 5-year retrospective study of 142 patients in a single institution. PLoS One (2013) 0.88
Vertebral arteria lusoria: a life-threatening condition for oesophageal surgery. Surg Radiol Anat (2011) 0.82
Navigation system for minimally invasive esophagectomy: experimental study in a porcine model. Surg Endosc (2013) 0.81
Robotic transthoracic esophagectomy. BMC Surg (2015) 0.81
Robot-assisted surgery: improved tool for major liver resections? J Hepatobiliary Pancreat Sci (2013) 0.81
Robotic surgery of the liver: Italian experience and review of the literature. Ecancermedicalscience (2013) 0.80
Laparoscopic gastric tube formation with pyloromyotomy for reconstruction in patients with esophageal cancer. Ann Surg Treat Res (2015) 0.79
Management of early-stage esophageal neoplasia (MESEN) consensus. World J Surg (2014) 0.77
Robotic esophagectomy: the Moffitt Cancer Center experience. Ann Cardiothorac Surg (2017) 0.75
Better perioperative outcomes in thoracoscopic-esophagectomy with two-lung ventilation in semi-prone position. J Thorac Dis (2017) 0.75
Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery. World J Gastroenterol (2016) 0.75
Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA. Avicenna J Med Biotechnol (2012) 0.75
Role of 3D in minimally invasive esophagectomy. Langenbecks Arch Surg (2017) 0.75
Oesophageal carcinoma. Lancet (2013) 5.48
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg (2012) 2.44
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg (2012) 2.14
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg (2003) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Minimally invasive operation for esophageal diverticula. Ann Thorac Surg (2005) 1.90
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg (2009) 1.68
Cervical pharyngostomy: an old technique revisited. Ann Surg (2008) 1.63
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
The laparoscopic approach to paraesophageal hernia repair. J Gastrointest Surg (2011) 1.62
Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol (2007) 1.60
Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg (2008) 1.60
Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg (2012) 1.60
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Should endobronchial ultrasonography be part of the thoracic surgeon's armamentarium? J Thorac Cardiovasc Surg (2009) 1.45
Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg (2008) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Contemporaneous management of esophageal perforation. Surgery (2009) 1.41
Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg (2011) 1.41
Anterior minithoracotomy: a direct approach to the difficult hilum for upper lobectomy, pneumonectomy, and sleeve lobectomy. Ann Surg Oncol (2009) 1.38
Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg (2009) 1.37
Technique of minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2010) 1.32
Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (2007) 1.31
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem (2007) 1.30
Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2006) 1.28
Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.28
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg (2005) 1.27
Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg (2008) 1.24
Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia (2006) 1.22
Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg (2012) 1.21
Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg (2009) 1.21
The management of flail chest. Thorac Surg Clin (2007) 1.20
Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res (2011) 1.20
Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer (2004) 1.20
Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg (2008) 1.17
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. J Thorac Cardiovasc Surg (2011) 1.15
Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res (2004) 1.14
Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma. Ann Thorac Surg (2007) 1.13
Patterns of recurrence and long-term survival after curative resection of localized fibrous tumors of the pleura. Clin Lung Cancer (2005) 1.12
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12
Sublobar resection for early-stage lung cancer. Semin Thorac Cardiovasc Surg (2010) 1.11
Esophageal cancer: an update. Int J Surg (2010) 1.10
MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg (2011) 1.10
Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg (2011) 1.08
Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors. J Surg Res (2009) 1.07
Anatomic segmentectomy for stage I non-small-cell lung cancer: comparison of video-assisted thoracic surgery versus open approach. J Thorac Cardiovasc Surg (2009) 1.07
Minimally invasive esophagectomy. Surg Clin North Am (2012) 1.07
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol (2013) 1.06
Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res (2005) 1.06
Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem (2004) 1.06
Minimally invasive esophagectomy for caustic esophageal stricture in children. J Pediatr Surg (2004) 1.05
Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients. JSLS (2004) 1.05
Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery (2009) 1.05
The "best operation" for esophageal cancer? Ann Thorac Surg (2010) 1.03
Acute, complete proximal small bowel obstruction after laparoscopic gastric bypass due to intraluminal blood clot formation. Surg Obes Relat Dis (2005) 1.03
Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg (2009) 1.03
Solitary sites of metastatic disease in non-small cell lung cancer. Curr Treat Options Oncol (2003) 1.03
Surgical management of epiphrenic diverticula in the minimally invasive era. JSLS (2009) 1.02
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol (2011) 1.01
Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. Lung Cancer (2003) 1.01
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg (2008) 0.97
Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (2009) 0.97
A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg (2006) 0.96
Radiofrequency and microwave ablation of lung tumors. J Surg Oncol (2009) 0.96
Impact of anastomotic leak on outcomes after transhiatal esophagectomy. Surgery (2010) 0.95
Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg (2004) 0.95
Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma. Clin Cancer Res (2011) 0.94
Polyflex expandable stents in the treatment of esophageal disease: initial experience. Ann Thorac Surg (2008) 0.94
Oncologic outcomes after surgical resection of subcentimeter non-small cell lung cancer. Ann Thorac Surg (2011) 0.94
Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells. J Thorac Cardiovasc Surg (2003) 0.94
Advanced age and sex as predictors of adverse outcomes following gastric bypass surgery. JSLS (2005) 0.91
Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin (2007) 0.91
Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis (2003) 0.91
A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res (2006) 0.91
Surgical aspects of the patient with high-grade dysplasia. Semin Thorac Cardiovasc Surg (2005) 0.90
Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol (2012) 0.90
Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem (2002) 0.90
Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann Thorac Surg (2011) 0.89
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.89
Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg (2011) 0.88
Technical challenges and utility of anterior exposure for thoracic spine pathology. Ann Thorac Surg (2008) 0.88
Pneumocephalus after resection of a lung cancer with posterior chest wall involvement. Ann Thorac Surg (2009) 0.88
Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J Surg Res (2007) 0.88